Feugiat nulla facilisis at vero eros et curt accumsan et iusto odio dignissim qui blandit praesent luptatum zzril.
+ (123) 1800-453-1546
info@example.com

Related Posts

Products

Faecal Occult Blood Test

The Biorex Diagnostics Faecal Occult Blood (FOB) One Step Test Device (faeces sample) is a rapid test to qualitatively detect low levels of faecal occult blood in faeces. The test uses double antibody sandwich assay to selectively detect as low as 50 ng/mL of hemoglobin or 6 µg hemoglobin/g faeces.  In addition, unlike the guaiac assays, the accuracy of the test is not affected by the diet of the patients.

Most of diseases can cause hidden blood in the stool. In the early stages, gastrointestinal problems such as colon cancer, ulcers, polyps, colitis, diverticulitis, and fissures may not show any visible symptoms, only occult blood. Traditional guaiac-based method lacks sensitivity and specificity, and has diet-restriction prior to the testing.

Add to Quote

Description

Product Name CAT.No Size
Faecal Occult Blood Test FOBC0020 20T
Faecal Occult Blood Test FOBC0040 40T

 

 

Product Description

The Biorex Diagnostics Faecal Occult Blood (FOB) One Step Test is a rapid immunochromatographic assay designed for the qualitative detection of hidden blood in human stool. It provides fast and reliable results to support early identification of gastrointestinal disorders, colorectal cancer screening, and preventive healthcare interventions.

Key Features
• Rapid detection – qualitative results within minutes
• High sensitivity – detects as low as 50 ng/mL haemoglobin or 6 µg/g faeces
• Dietary-independent – accuracy unaffected by food or medication
• Non-invasive testing – uses a simple stool sample
• Ready-to-use format – minimal preparation, simple interpretation, reduced errors

Benefits
Use of the FOB One Step Test enables early detection of gastrointestinal bleeding, supporting timely clinical intervention and preventive health programmes. Its rapid workflow, high accuracy, and patient-friendly design enhance colorectal cancer screening, diagnostic evaluation of GI disorders, and follow-up monitoring, improving patient outcomes in both clinical and laboratory settings.

Additional information

Storage

2-8°C